A new drug-device combination therapy could make a tremendous impact for mental health patients who are often challenged with nonadherence to treatment regimens.

A company developing an imaging system for breast cancer screening is getting noticed in the venture capital community. Delphinus Medical Technologies (Plymouth Township, Mich.) has raised $39.5 million in a Series C financing round.